Cargando…

The impact of antimicrobial management by clinical pharmacists in obstetrics and gynecology on antimicrobial indicators, bacterial resistance and drug costs from 2011 to 2021 in China

OBJECTIVES: The goal of our study is to analyze the effectiveness and role of clinical pharmacists in antibiotic management through retrospective research from 2011 to 2021, depending on the current scenario of the antibiotic application in China. METHODS: We formed a team of pharmacists to carry ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Jing, Zhu, JiaLei, Tang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300213/
https://www.ncbi.nlm.nih.gov/pubmed/37389079
http://dx.doi.org/10.1016/j.heliyon.2023.e16851
_version_ 1785064539190984704
author Jin, Jing
Zhu, JiaLei
Tang, Jing
author_facet Jin, Jing
Zhu, JiaLei
Tang, Jing
author_sort Jin, Jing
collection PubMed
description OBJECTIVES: The goal of our study is to analyze the effectiveness and role of clinical pharmacists in antibiotic management through retrospective research from 2011 to 2021, depending on the current scenario of the antibiotic application in China. METHODS: We formed a team of pharmacists to carry out multifaceted intervention measures, such as forming a working group, developing a plan, establishing management rules via the pre-trial system, prescription comments, collaborating with the administrative department, implementing training and publicity, and so on. Antibiotic use was studied, bacterial drug resistance was determined, and antibiotic costs were computed. RESULTS: The pharmacist intervention and rectification of inappropriate antibacterial drug orders considerably enhanced the rational use rate of antibiotics and reduced the cost of antibiotics. Antibiotic use in clean surgery decreased from 90.22% to 11.14%, the use rate of antibiotics decreased from 63.82% to 30.26%, and antibiotic use intensity decreased from 42.75DDDs to 30.04DDDs. The types, timing, and course of antibacterials used in wards were all improved to varying degrees. Bacterial drug resistance improved noticeably, with resistance of Escherichia coli to cephalosporins, ciprofloxacin and carbapenems decreased in varying degrees. The use of antibacterial drugs has decreased significantly. CONCLUSIONS: It is feasible and effective for pharmacists in gynecology and obstetrics to control antibiotic use, which plays a positive role in promoting the safe, effective, and cost-effective use of antibiotics and serves as a valuable reference for the antibiotic management.
format Online
Article
Text
id pubmed-10300213
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103002132023-06-29 The impact of antimicrobial management by clinical pharmacists in obstetrics and gynecology on antimicrobial indicators, bacterial resistance and drug costs from 2011 to 2021 in China Jin, Jing Zhu, JiaLei Tang, Jing Heliyon Research Article OBJECTIVES: The goal of our study is to analyze the effectiveness and role of clinical pharmacists in antibiotic management through retrospective research from 2011 to 2021, depending on the current scenario of the antibiotic application in China. METHODS: We formed a team of pharmacists to carry out multifaceted intervention measures, such as forming a working group, developing a plan, establishing management rules via the pre-trial system, prescription comments, collaborating with the administrative department, implementing training and publicity, and so on. Antibiotic use was studied, bacterial drug resistance was determined, and antibiotic costs were computed. RESULTS: The pharmacist intervention and rectification of inappropriate antibacterial drug orders considerably enhanced the rational use rate of antibiotics and reduced the cost of antibiotics. Antibiotic use in clean surgery decreased from 90.22% to 11.14%, the use rate of antibiotics decreased from 63.82% to 30.26%, and antibiotic use intensity decreased from 42.75DDDs to 30.04DDDs. The types, timing, and course of antibacterials used in wards were all improved to varying degrees. Bacterial drug resistance improved noticeably, with resistance of Escherichia coli to cephalosporins, ciprofloxacin and carbapenems decreased in varying degrees. The use of antibacterial drugs has decreased significantly. CONCLUSIONS: It is feasible and effective for pharmacists in gynecology and obstetrics to control antibiotic use, which plays a positive role in promoting the safe, effective, and cost-effective use of antibiotics and serves as a valuable reference for the antibiotic management. Elsevier 2023-06-12 /pmc/articles/PMC10300213/ /pubmed/37389079 http://dx.doi.org/10.1016/j.heliyon.2023.e16851 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Jin, Jing
Zhu, JiaLei
Tang, Jing
The impact of antimicrobial management by clinical pharmacists in obstetrics and gynecology on antimicrobial indicators, bacterial resistance and drug costs from 2011 to 2021 in China
title The impact of antimicrobial management by clinical pharmacists in obstetrics and gynecology on antimicrobial indicators, bacterial resistance and drug costs from 2011 to 2021 in China
title_full The impact of antimicrobial management by clinical pharmacists in obstetrics and gynecology on antimicrobial indicators, bacterial resistance and drug costs from 2011 to 2021 in China
title_fullStr The impact of antimicrobial management by clinical pharmacists in obstetrics and gynecology on antimicrobial indicators, bacterial resistance and drug costs from 2011 to 2021 in China
title_full_unstemmed The impact of antimicrobial management by clinical pharmacists in obstetrics and gynecology on antimicrobial indicators, bacterial resistance and drug costs from 2011 to 2021 in China
title_short The impact of antimicrobial management by clinical pharmacists in obstetrics and gynecology on antimicrobial indicators, bacterial resistance and drug costs from 2011 to 2021 in China
title_sort impact of antimicrobial management by clinical pharmacists in obstetrics and gynecology on antimicrobial indicators, bacterial resistance and drug costs from 2011 to 2021 in china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300213/
https://www.ncbi.nlm.nih.gov/pubmed/37389079
http://dx.doi.org/10.1016/j.heliyon.2023.e16851
work_keys_str_mv AT jinjing theimpactofantimicrobialmanagementbyclinicalpharmacistsinobstetricsandgynecologyonantimicrobialindicatorsbacterialresistanceanddrugcostsfrom2011to2021inchina
AT zhujialei theimpactofantimicrobialmanagementbyclinicalpharmacistsinobstetricsandgynecologyonantimicrobialindicatorsbacterialresistanceanddrugcostsfrom2011to2021inchina
AT tangjing theimpactofantimicrobialmanagementbyclinicalpharmacistsinobstetricsandgynecologyonantimicrobialindicatorsbacterialresistanceanddrugcostsfrom2011to2021inchina
AT jinjing impactofantimicrobialmanagementbyclinicalpharmacistsinobstetricsandgynecologyonantimicrobialindicatorsbacterialresistanceanddrugcostsfrom2011to2021inchina
AT zhujialei impactofantimicrobialmanagementbyclinicalpharmacistsinobstetricsandgynecologyonantimicrobialindicatorsbacterialresistanceanddrugcostsfrom2011to2021inchina
AT tangjing impactofantimicrobialmanagementbyclinicalpharmacistsinobstetricsandgynecologyonantimicrobialindicatorsbacterialresistanceanddrugcostsfrom2011to2021inchina